Neoadjuvant chemotherapy reduces operative morbidity without effecting time to recurrence in advanced stage epithelial ovarian cancer

Journal article

Peer reviewed

S.E. Taylor, J. Berger, K. Johnson, M.M. Boisen, M.B. Courtney-Brooks, P. Sukumvanich, J.L. Kelley and M. Huang

Gynecologic oncology, Vol.137, pp.117-118

2015-04

Metrics

3 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.128 Fertility, Endometriosis & Hysterectomy; 1.128.390 Ovarian Cancer
Web Of Science research areas: Obstetrics & Gynecology; Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Neoadjuvant chemotherapy reduces operative morbidity without effecting time to recurrence in advanced stage epithelial ovarian cancer
Creators: S.E. Taylor - Magee-Womens Hospital
J. Berger - Magee-Womens Hospital
K. Johnson - Magee-Womens Hospital
M.M. Boisen - Magee-Womens Hospital
M.B. Courtney-Brooks - Magee-Womens Hospital
P. Sukumvanich - Magee-Womens Hospital
J.L. Kelley - Magee-Womens Hospital
M. Huang - Magee-Womens Hospital
Publication Details: Gynecologic oncology, Vol.137, pp.117-118
Academic Unit: Miller School of Medicine; UMMG Dept of Obstetrics & Gynecology
Language: English
Resource Type: Journal article
Record Identifier: 991031713689302976